产品: 磷酸化 DNA-PK (Thr2647) 抗体
货号: AF3360
描述: Rabbit polyclonal antibody to Phospho-DNA-PK (Thr2647)
应用: WB IHC IF/ICC
文献验证: WB
反应: Human
蛋白号: P78527
RRID: AB_2834775

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1300 现货
 100ul RMB¥ 2400 现货
 200ul RMB¥ 3200 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
IHC 1:50-1:200, IF/ICC 1:100-1:500, WB 1:500-1:2000
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human
克隆:
Polyclonal
特异性:
Phospho-DNA-PK (Thr2647) Antibody detects endogenous levels of DNA-PK only when phosphorylated at Threonine 2647.
RRID:
AB_2834775
引用格式: Affinity Biosciences Cat# AF3360, RRID:AB_2834775.
偶联:
Unconjugated.
纯化:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

DNA dependent protein kinase catalytic subunit; DNA PK catalytic subunit; DNA-dependent protein kinase catalytic subunit; DNA-PK catalytic subunit; DNA-PKcs; DNAPK; DNAPK catalytic subunit; DNPK 1; DNPK1; Hyper radiosensitivity of murine scid mutation, complementing 1; Hyperradiosensitivity complementing 1, mouse, homolog of 1; HYRC 1; HYRC; HYRC1; IMD26; p350; p460; PKRDC; PRKDC; PRKDC_HUMAN; Protein Kinase DNA Activated Catalytic Polypeptide; XRCC 7; XRCC7;

抗原和靶标

免疫原:

A synthesized peptide derived from human DNA-PK around the phosphorylation site of Thr2647.

基因/基因ID:
描述:
The PRKDC gene encodes the catalytic subunit of a nuclear DNA-dependent serine/threonine protein kinase (DNA-PK). The second component is the autoimmune antigen Ku (MIM 152690), which is encoded by the G22P1 gene on chromosome 22q.

研究领域

· Cellular Processes > Cell growth and death > Cell cycle.   (View pathway)

· Genetic Information Processing > Replication and repair > Non-homologous end-joining.

文献引用

1). Network Pharmacology-Based Strategy to Identify the Pharmacological Mechanisms of Pulsatilla Decoction against Crohn's Disease. Frontiers in Pharmacology, 2022 (PubMed: 35450039) [IF=5.6]

Application: WB    Species: Human    Sample:

FIGURE 5 Expression of AKT/mTOR and PKCs/ERK1/2 in stenoses and nonstenoses of CD patients. (A) Western blotting showing the relative protein intensities of p-AKT, AKT, p-mTOR, mTOR, p-ERK1/2, ERK1/2, p-PKCs, PKCs, vimentin, and α-SMA. (B–D) Real-time quantitative qPCR showing the relative levels of (B) AKT and mTOR mRNAs, (C) PKCs and ERK1/2 mRNAs, and (D) vimentin and α-SMA mRNAs. (E,F) Immunohistochemistry of (E) PKCs and (F) ERK1/2. Scale bars: 50 μm, magnification: ×400. S, stenoses; NS, non-stenoses.

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.